KIAA1109 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.506200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.828350E-01
Normal-vs-Stage2
1.705650E-02
Normal-vs-Stage3
3.582300E-02
Normal-vs-Stage4
5.837200E-01
Stage1-vs-Stage2
4.448600E-01
Stage1-vs-Stage3
2.525900E-02
Stage1-vs-Stage4
5.009200E-01
Stage2-vs-Stage3
8.262100E-02
Stage2-vs-Stage4
1.285580E-01
Stage3-vs-Stage4
5.866100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.244400E-02
Normal-vs-AfricanAmerican
2.043000E-01
Normal-vs-Asian
3.597800E-02
Caucasian-vs-AfricanAmerican
8.387800E-01
Caucasian-vs-Asian
2.632600E-01
AfricanAmerican-vs-Asian
3.274200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.222100E-02
Normal-vs-Female
1.355050E-01
Male-vs-Female
2.129800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.881400E-01
Normal-vs-Age(41-60Yrs)
2.643800E-01
Normal-vs-Age(61-80Yrs)
3.016200E-02
Normal-vs-Age(81-100Yrs)
8.295900E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.787200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.673800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.341600E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.423800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.738020E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.367400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.452150E-02
Normal-vs-Daily Drinker
1.966220E-02
Normal-vs-Weekly Drinker
3.108400E-02
Normal-vs-Occasional Drinker
2.591400E-01
Normal-vs-Social Drinker
5.269000E-01
Non Drinker-vs-Daily Drinker
8.606800E-01
Non Drinker-vs-Weekly Drinker
7.553800E-01
Non Drinker-vs-Occasional Drinker
1.175390E-01
Non Drinker-vs-Social Drinker
2.073000E-01
Daily Drinker-vs-Weekly Drinker
8.825600E-01
Daily Drinker-vs-Occasional Drinker
1.247630E-01
Daily Drinker-vs-Social Drinker
1.883180E-01
Weekly Drinker-vs-Occasional Drinker
1.577380E-01
Weekly Drinker-vs-Social Drinker
1.784430E-01
Occasional Drinker-vs-Social Drinker
7.487400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.090560E-01
Normal-vs-Grade 2
1.675250E-03
Normal-vs-Grade 3
1.600320E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.055800E-01
Grade 1-vs-Grade 3
6.209600E-01
Grade 1-vs-Grade 4
1.090560E-01
Grade 2-vs-Grade 3
2.134200E-01
Grade 2-vs-Grade 4
1.675250E-03
Grade 3-vs-Grade 4
1.600320E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.303500E-03
Normal-vs-NonDiabetic
9.238100E-02
Diabetic-vs-NonDiabetic
1.477580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.889900E-02
Normal-vs-NoPancreatitis
6.458100E-02
Pancreatitis-vs-NoPancreatitis
9.867800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.549000E-01
Normal-vs-N1
1.590370E-02
N0-vs-N1
4.852800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.303600E-02
Normal-vs-TP53-NonMutant
3.243400E-01
TP53-Mutant-vs-TP53-NonMutant
1.455010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
